Company Information for IOVANCE BIOTHERAPEUTICS UK SP LTD
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT,
|
Company Registration Number
08588212
Private Limited Company
Active |
Company Name | ||
---|---|---|
IOVANCE BIOTHERAPEUTICS UK SP LTD | ||
Legal Registered Office | ||
3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM CHESHIRE WA14 2DT Other companies in DE14 | ||
Previous Names | ||
|
Company Number | 08588212 | |
---|---|---|
Company ID Number | 08588212 | |
Date formed | 2013-06-27 | |
Country | UNITED KINGDOM | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 30/06/2022 | |
Account next due | 30/09/2024 | |
Latest return | 27/06/2016 | |
Return next due | 25/07/2017 | |
Type of accounts | AUDIT EXEMPTION SUBSIDIARY |
Last Datalog update: | 2023-12-06 23:49:13 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
AMANDA MILLER |
||
MARTIN JAMES ABELL |
||
SHAUN EDWARD CHILTON |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
MARTIN JAMES ABELL |
Company Secretary | ||
JAMES SIDNEY HADDLETON |
Company Secretary | ||
PETER LUTZ GEORGE |
Director | ||
ROBIN ANDREW JOHN SIBSON |
Director | ||
ROBIN ANDREW JOHN SIBSON |
Company Secretary |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
IDIS MA LIMITED | Director | 2016-01-21 | CURRENT | 2016-01-21 | Active - Proposal to Strike off | |
IDIS PHARMA LIMITED | Director | 2016-01-21 | CURRENT | 2016-01-21 | Active - Proposal to Strike off | |
IDIS GA LIMITED | Director | 2016-01-21 | CURRENT | 2016-01-21 | Active - Proposal to Strike off | |
CLINIGEN CTS LIMITED | Director | 2015-12-01 | CURRENT | 2004-01-15 | Active | |
CLINIGEN CONSULTING LIMITED | Director | 2015-12-01 | CURRENT | 2007-10-24 | Active - Proposal to Strike off | |
CLINIGEN PHARMA LIMITED | Director | 2015-12-01 | CURRENT | 2010-05-10 | Active | |
CLINIGEN GAP LIMITED | Director | 2015-12-01 | CURRENT | 2011-12-02 | Active - Proposal to Strike off | |
CLINIGEN CLINICAL TRIALS LIMITED | Director | 2015-12-01 | CURRENT | 2003-06-27 | Active - Proposal to Strike off | |
IDIS GROUP LIMITED | Director | 2015-12-01 | CURRENT | 2004-10-25 | Active | |
IDIS LIMITED | Director | 2015-12-01 | CURRENT | 1987-06-29 | Active | |
IDIS GROUP HOLDINGS LIMITED | Director | 2015-12-01 | CURRENT | 2005-03-11 | Active | |
CLINIGEN HEALTHCARE LIMITED | Director | 2015-12-01 | CURRENT | 2007-05-18 | Active | |
KEATS HEALTHCARE LIMITED | Director | 2015-12-01 | CURRENT | 2008-05-15 | Active - Proposal to Strike off | |
CLINIGEN LIMITED | Director | 2015-08-03 | CURRENT | 2008-12-12 | Active | |
CLINIGEN HOLDINGS LIMITED | Director | 2017-06-06 | CURRENT | 2017-02-14 | Active | |
CLINIGEN INTERNATIONAL HOLDINGS LIMITED | Director | 2017-06-06 | CURRENT | 2017-02-14 | Active | |
IDIS MA LIMITED | Director | 2016-01-21 | CURRENT | 2016-01-21 | Active - Proposal to Strike off | |
IDIS PHARMA LIMITED | Director | 2016-01-21 | CURRENT | 2016-01-21 | Active - Proposal to Strike off | |
IDIS GA LIMITED | Director | 2016-01-21 | CURRENT | 2016-01-21 | Active - Proposal to Strike off | |
CLINIGEN CONSULTING LIMITED | Director | 2015-04-29 | CURRENT | 2007-10-24 | Active - Proposal to Strike off | |
IDIS GROUP LIMITED | Director | 2015-04-29 | CURRENT | 2004-10-25 | Active | |
IDIS LIMITED | Director | 2015-04-29 | CURRENT | 1987-06-29 | Active | |
IDIS GROUP HOLDINGS LIMITED | Director | 2015-04-29 | CURRENT | 2005-03-11 | Active | |
CLINIGEN PHARMA LIMITED | Director | 2014-04-01 | CURRENT | 2010-05-10 | Active | |
CLINIGEN GAP LIMITED | Director | 2014-04-01 | CURRENT | 2011-12-02 | Active - Proposal to Strike off | |
CLINIGEN CLINICAL TRIALS LIMITED | Director | 2014-04-01 | CURRENT | 2003-06-27 | Active - Proposal to Strike off | |
KEATS HEALTHCARE LIMITED | Director | 2014-04-01 | CURRENT | 2008-05-15 | Active - Proposal to Strike off | |
CLINIGEN HEALTHCARE LIMITED | Director | 2013-10-18 | CURRENT | 2007-05-18 | Active | |
CLINIGEN LIMITED | Director | 2013-07-11 | CURRENT | 2008-12-12 | Active | |
CLINIGEN CTS LIMITED | Director | 2012-03-01 | CURRENT | 2004-01-15 | Active |
Date | Document Type | Document Description |
---|---|---|
Current accounting period extended from 30/06/23 TO 31/12/23 | ||
CONFIRMATION STATEMENT MADE ON 31/05/23, WITH NO UPDATES | ||
REGISTERED OFFICE CHANGED ON 12/06/23 FROM Pitcairn House Crown Square Centrum 100 Burton-on-Trent Staffordshire DE14 2WW | ||
Notification of Iovance Biotherapeutics Uk Ltd as a person with significant control on 2023-05-18 | ||
CESSATION OF CLINIGEN HOLDINGS LIMITED AS A PERSON OF SIGNIFICANT CONTROL | ||
DIRECTOR APPOINTED MR FREDERICK VOGT | ||
DIRECTOR APPOINTED MR JEAN-MARC BELLEMIN | ||
APPOINTMENT TERMINATED, DIRECTOR RICHARD JOHN PALING | ||
Resolutions passed:<ul><li>Resolution Cancel share premium 28/04/2023</ul> | ||
Solvency Statement dated 28/04/23 | ||
Statement by Directors | ||
Statement of capital on USD 18,000,000 | ||
Termination of appointment of Amanda Miller on 2023-01-16 | ||
TM01 | APPOINTMENT TERMINATED, DIRECTOR SHAUN EDWARD CHILTON | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/22, WITH UPDATES | |
PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 30/06/21 | |
AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 30/06/21 | |
GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 30/06/21 | |
AP01 | DIRECTOR APPOINTED MR RICHARD JOHN PALING | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR NICHOLAS PATRICK KEHER | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/21, WITH NO UPDATES | |
RP04CS01 | ||
PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 30/06/20 | |
AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 30/06/20 | |
GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 30/06/20 | |
AA | FULL ACCOUNTS MADE UP TO 30/06/19 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/20, WITH UPDATES | |
SH01 | 04/11/19 STATEMENT OF CAPITAL GBP 1 | |
RES12 | Resolution of varying share rights or name | |
PSC02 | Notification of Clinigen Holdings Limited as a person with significant control on 2019-03-27 | |
PSC07 | CESSATION OF CLINIGEN PHARMA LIMITED AS A PERSON OF SIGNIFICANT CONTROL | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/19, WITH UPDATES | |
SH01 | 22/05/19 STATEMENT OF CAPITAL GBP 1 | |
AP01 | DIRECTOR APPOINTED NICHOLAS PATRICK KEHER | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MARTIN JAMES ABELL | |
AAMD | Amended dormat accounts made up to 2018-06-30 | |
CS01 | CONFIRMATION STATEMENT MADE ON 31/05/18, WITH UPDATES | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 30/06/17 | |
PSC02 | Notification of Clinigen Pharma Limited as a person with significant control on 2017-06-28 | |
AP03 | Appointment of Amanda Miller as company secretary on 2017-07-13 | |
TM02 | Termination of appointment of Martin James Abell on 2017-07-13 | |
LATEST SOC | 05/07/17 STATEMENT OF CAPITAL;GBP 1 | |
CS01 | CONFIRMATION STATEMENT MADE ON 27/06/17, WITH UPDATES | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 30/06/16 | |
AP03 | Appointment of Mr Martin James Abell as company secretary on 2017-03-02 | |
TM02 | Termination of appointment of James Sidney Haddleton on 2017-03-02 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR PETER LUTZ GEORGE | |
LATEST SOC | 27/06/16 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 27/06/16 ANNUAL RETURN FULL LIST | |
AA | ACCOUNTS OF DORMANT COMPANY MADE UP TO 30/06/15 | |
AA | ACCOUNTS OF DORMANT COMPANY MADE UP TO 30/06/15 | |
AP01 | DIRECTOR APPOINTED MR MARTIN ABELL | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ROBIN ANDREW JOHN SIBSON | |
AP03 | Appointment of Mr James Sidney Haddleton as company secretary on 2015-11-02 | |
TM02 | APPOINTMENT TERMINATED, SECRETARY ROBIN SIBSON | |
TM02 | APPOINTMENT TERMINATED, SECRETARY ROBIN SIBSON | |
LATEST SOC | 07/07/15 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 27/06/15 ANNUAL RETURN FULL LIST | |
AA | ACCOUNTS FOR DORMANT COMPANY MADE UP TO 30/06/14 | |
LATEST SOC | 02/07/14 STATEMENT OF CAPITAL;GBP 1 | |
AR01 | 27/06/14 ANNUAL RETURN FULL LIST | |
AP01 | DIRECTOR APPOINTED SHAUN EDWARD CHILTON | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / PETER LUTZ GEORGE / 23/11/2013 | |
MODEL ARTICLES | MODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max |
This shows the max and average number of mortgages for companies with the same SIC code of 46460 - Wholesale of pharmaceutical goods
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on IOVANCE BIOTHERAPEUTICS UK SP LTD
The top companies supplying to UK government with the same SIC code (46460 - Wholesale of pharmaceutical goods) as IOVANCE BIOTHERAPEUTICS UK SP LTD are:
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |